Sign In

Assaf Bivas

CEO & Co-Founder at Pollen Innovation Group

Assaf Bivas is the CEO and Co-Founder of Pollen Group, an investment and innovation company.13 He is also the CEO of ODE Pharma, a biotech startup focused on developing treatments for respiratory disorders, particularly cystic fibrosis in children.1

Bivas has a diverse background in entrepreneurship, investment, innovation, and leadership. His experience includes:

  1. Leading ODE Pharma's development of a novel molecule (ODE-001) derived from papaya, which shows promise in treating cystic fibrosis and other respiratory conditions.1

  2. Co-founding the Pollen Innovation Group, which backs ventures like ODE Pharma.1

  3. Involvement in various business sectors, including green energy and music production.23

Bivas is actively engaged in fundraising and business development, with ODE Pharma recently raising $1.5 million and seeking an additional $5 million.1 His leadership style appears to focus on combining profit-driven business with socially impactful initiatives, as evidenced by ODE Pharma's mission to improve the lives of those affected by respiratory conditions.1

Highlights

Sep 4 · nocamels.com
Startup sees potential of papaya to treat cystic fibrosis in kids

Related Questions

What inspired Assaf Bivas to co-found Pollen Group?
How did Assaf Bivas transition from music production to biotech?
What are the main goals of Pollen Group under Assaf Bivas' leadership?
How does ODE-001 work to treat cystic fibrosis in children?
What other projects is Pollen Group currently working on?
Assaf Bivas
Assaf Bivas, photo 1
Assaf Bivas, photo 2
Add to my network

Location

Tel Aviv, Israel